Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’...
Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists
East Lyme, Connecticut, USA: Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites...
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
Sanofi and Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of life-threatening diseases,...
New Functionality Added to Thermo Scientific SampleManager LIMS software for Manufacturing QA/QC and Contract Laboratories
In response to the data management needs of manufacturing QA/QC and contract laboratories, the latest version of SampleManager Laboratory Information Management System (LIMS) software...
Sirio Europe invest in advanced manufacturing and green technologies at Brandenburg site
Sirio Europe – the leading European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), part of the Sirio group – announces the completion...
ATMPS advanced therapy blockchain platform has successful testing with NHS partners
ATMPS Ltd – a spinout of FarmaTrust announces that its Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s...
NIH initiates phase 3 clinical trial to test immune modulators for treatment of COVID-19
The National Institutes of Health (NIH) has launched an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...